Monaghan Medical

Monaghan Medical is a private, commercial-stage leader in the respiratory medical device sector, with a 40+ year history. The company's core business revolves around designing and manufacturing a portfolio of inhalation aids, including valved holding chambers (e.g., AeroChamber series), nebulizers (e.g., AeroEclipse), OPEP devices (e.g., Aerobika), and peak flow meters. It operates with a dual customer model, serving both end patients/caregivers via prescription and major pharmaceutical companies as a drug delivery device partner. With a state-of-the-art aerosol research lab and a strong emphasis on clinical evidence, Monaghan is positioned in the large and growing global market for chronic respiratory disease management.

Aerosol science and precision engineering platform for pulmonary drug delivery, supported by the Aerosol & Airway Institute. Core technologies include Valved Holding Chambers (VHC), Breath-Actuated Nebulizers (BAN), and Oscillating Positive Expiratory Pressure (OPEP) devices, all focused on efficient lung deposition, reduced waste, and infection control.

Monaghan competes in the respiratory device market against large, diversified medtech companies (e.g., Philips Respironics, Omron, Vyaire Medical) and other specialized device makers. Its differentiation is based on deep aerosol science expertise, a focus on clinically-validated designs, and a portfolio spanning VHCs, nebulizers, and OPEP therapy.